ITAÚ UNIBANCO - Material Fact: Payment of Interest on Capital
ITAÚ UNIBANCO - Material Fact: Payment of Interest on Capital
PR Newswire
SÃO PAULO, Aug. 29, 2024
SÃO PAULO, Aug. 29, 2024 /PRNewswire/ -- MATERIAL FACT:
ITAÚ UNIBANCO HOLDING S.A. informs its stockholders that its Board of Directors has approved, at the meeting held on this date, the payment of interest on capital to stockholders ("IOC") in the amount of R$0.27298 per share, with income tax withholding at a rate of 15%, resulting in net interest of R$0.232033 per share, except for the corporate stockholders able to prove that they are immune or exempt from such withholding, which will be made until April 30, 2025. The calculation will be based on the final stockholding position recorded on September 19, 2024, with their shares traded "ex-rights" starting September 20, 2024.
For further information, please visit on www.itau.com.br/investor-relations as follows: Menu > Investor Services > Contact IR.
GUSTAVO LOPES RODRIGUES
Investor Relations Officer
Note: The amounts paid per share as interest on capital are the same for common (ITUB3) and preferred (ITUB4) shares.
Contact: Itaú Unibanco – Comunicação Corporativa, (11) 5019-8880 / 8881, imprensa@itau-unibanco.com.br
View original content:https://www.prnewswire.com/news-releases/itau-unibanco---material-fact-payment-of-interest-on-capital-302234553.html
SOURCE Itaú Unibanco Holding S.A.
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now